Prader-Willi Syndrome clinical trials at UC Irvine
2 in progress, 1 open to eligible people
Showing trials for
Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
open to eligible people ages 5-30
12-week, randomized, double-blind, placebo-controlled, parallel-group study of carbetocin nasal spray for the treatment of hyperphagia in Prader-Willi syndrome (PWS)
Orange, California and other locations
DCCR in Patients With Prader-Willi Syndrome
Sorry, in progress, not accepting new patients
The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.
Orange, California and other locations
Last updated: